ABOUT US
General information
Institutional collaborations
Strategy and Funding
Contact
Technology & Business Development Office
Administration
Alumni
Open Science
Science and society
Gender Equality, Diversity and Inclusion (GEDI)
Donate
RESEARCH
Faculty members
Staff Scientists
Faculty Alumni
Research Programmes
Scientific Publications
Projects
Barcelona Collaboratorium
SCIENTIFIC SERVICES
Core Technologies Programme
Scientific resources
European Genome-Phenome Archive
PRBB μFabLab
Neuroscience Resources
CAREERS
HR Excellence - HRS4R
Job opportunities
Group Leader Recruitment
Relocation to Barcelona
Career development
Working at CRG
TRAINING
Undergraduates and masters
PhD Students
Postdoctoral Researchers
Courses
TECH TRANSFER
EVENTS
Events
CRG Scientific Sessions
PRBB-CRG Sessions
PRBB Scientific Sessions
PRBB Computational Genomics Seminars
Outreach Activities
Courses
NEWS
News
CRG in the Media
Institutional Publications
Search
You are here
You are here:
Home
> PerkinElmer’s Sirion to develop new generation AAV vectors for diabetes gene therapy
PerkinElmer’s Sirion to develop new generation AAV vectors for diabetes gene therapy
PerkinElmer’s Sirion to develop new generation AAV vectors for diabetes gene therapy
Biopharma Reporter
February 21, 2022
PerkinElmer’s Sirion to develop new generation AAV vectors for diabetes gene therapy
Learn more
PerkinElmer’s Sirion to develop new generation AAV vectors for diabetes gene therapy